PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsstaphylococcal infections
MeSH D013203 - staphylococcal infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D016908:Gram-positive bacterial infections
$
Success rate
D013203: 
Staphylococcal infections
D011023:Staphylococcal pneumonia
0 Companies
0 Drugs
Success rate
D013202:Staphylococcal food poisoning
0 Companies
0 Drugs
Success rate
D013207:Staphylococcal skin infections
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaCeftriaxone Ceftriaxone  2007-03-15   
Cefazolin Cefazolin  1989-03-14   
Clindamycin Clindamycin  1989-09-20   
Amoxicillin, Clavulanic acid Amoxicillin Clavulanate Potassium  2004-05-25   
Linezolid Linezolid  2015-05-18   
Sulfamethoxazole, Trimethoprim Cotrim  1985-05-16   
Sulfamethoxazole, Trimethoprim Cotrim D.s  1985-03-18   
Sulfamethoxazole, Trimethoprim Sulfamethoxazole Trimethoprim  1991-10-31   
Trimethoprim Trimethoprim  1987-06-18   
Vancomycin Vancomycin  2015-12-23   
Cephalexin Cephalexin  1982-01-01   
Tobramycin Tobramycin  1992-01-30   
Ciprofloxacin Ciprofloxacin  2004-06-09   
Levofloxacin Levofloxacin  2011-06-20   
Ofloxacin Ofloxacin  2003-09-02   
Oxacillin Oxacillin  1982-01-01   
Novast LaboratoriesClindamycin Clindamycin  1996-09-27   
PadagisClindamycin Clindamycin  1995-11-30   
Clindamycin, Benzoyl peroxide Clindamycin Benzoyl Peroxide  2012-06-26   
Clindamycin Clinderm  1992-09-30   
Clindamycin Clindesse 2023-04-27 2004-11-30   
Clindamycin Clindets  1996-09-30   
Dexamethasone, Tobramycin Tobramycin Dexamethasone  2022-02-11   
Hydrocortisone, Bacitracin, Neomycin, Polymyxin b Bacitracin-neomycin-polymyxin W/ Hydrocortisone  1982-01-01   
Taro PharmaceuticalClindamycin Clindamycin  2004-03-31   
Clindamycin, Benzoyl peroxide Clindamycin Benzoyl Peroxide  2017-12-15   
Ciprofloxacin Ciprofloxacin  2004-10-06   
Glenmark PharmaceuticalsClindamycin Clindamycin  2021-09-20   
Clindamycin, Benzoyl peroxide Clindamycin Benzoyl Peroxide  2019-03-14   
Linezolid Linezolid  2015-12-21   
Sulfamethoxazole, Trimethoprim Sulfamethoxazole Trimethoprim  2010-12-22   
Levofloxacin Levofloxacin  2011-06-20   
MylanClindamycin Clindamycin  2011-05-31   
Clindamycin, Benzoyl peroxide Clindamycin Benzoyl Peroxide  2009-08-11   
Clindamycin Evoclin 2024-01-23 2004-10-22   
Rifampin Rifampin  2008-05-22   
Linezolid Linezolid  2017-12-06   
Sulfamethoxazole, Trimethoprim Sulfamethoxazole Trimethoprim  2017-08-30   
Vancomycin Vancomycin  2008-12-30   
Tobramycin Tobi  1997-12-22   
Tobramycin Tobramycin  2008-03-11   
Ciprofloxacin Ciprofloxacin  2004-06-09   
Levofloxacin Levofloxacin  2011-06-20   
Johnson & JohnsonLevofloxacin Levaquin  1996-12-20   
Ofloxacin Floxin  1990-12-28   
AlmirallClindamycin, Tretinoin Veltin  2010-07-16   
GSKCefazolin Ancef  1982-01-01   
Cefazolin Cefazolin  1993-10-31   
Ticarcillin, Clavulanic acid Timentin  1985-04-01   
Nafcillin Nallpen  1982-01-01   
Oxacillin Bactocill  1982-01-01   
RocheCeftriaxone, Lidocaine Rocephin  1985-03-12 $261.442 M Y2021 
Trimethoprim Trimpex  1982-01-01   
1
2
3
4
5
6
...
22
>
Clinical Trials
Historical Success Rate
Phase 1
25%
2/8
Phase 2
100%
8/8
Phase 3
98%
86/88
Approved: 76Overall Success rate: 24%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
1
2
3
4
5
6
...
15
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use